课题基金 / 基金详情

项目摘要

项目成果

TERRY V ZENSER的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We propose to continue defining specific mechanisms involved in initiation of chemically-induced bladder cancer. The N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide (FANFT) model was chosen because of flexibility in experimental design permitted by a high incidence of the desired lesion. Hypotheses forming the basis of our proposal are: 1) Certain specific physiologic and metabolic functions are responsible for the delivery of high concentrations of the more proximate deformylated carcinogen, ANFT, to urothelium. 2) Metabolic activation occurs in urothelial cells with oxidation of ANFT by prostaglandin H synthase (PHS) a likely mechanism of activation. Other pathways may also be involved. 3) Agents which decrease the amount of ANFT accessible to bladder epithelium, prevent activation in bladder and/or prevent activated intermediates from binding DNA will reduce the incidence of FANFT-induced bladder cancer. FANFT-ANFT metabolism and disposition will be assessed by intact rat and guinea pig, species susceptible and resistant, respectively, to FANFT-induced bladder cancer. Target tissue metabolism will be assessed with urothelial cells from rat, human and guinea pig. Tissue distribution, covalent binding and chromatographically separable metabolite determiantions will be facilitated by the use of 14C- and 35S-labeled FANFT-ANFT. Renal FANFT deformylase purified from rat will be characterized. Urothelial cell synthesis of eicosanoid substrates of PHS will also be assessed. Biologic assessment will include cell transformation and urothelial cell toxicity evaluation of ANFT and its metabolites. The in vivo method will use the two-stage FANFT model to evaluate effects of dietary factors on physiologic (urine pH) and metabolic (activation) parameters of FANFT initiation. Each set of experiments will continuously test our hypotheses by the selection of agents which alter metabolism and disposition and ameliorate pathogenic processes. Data obtained from this renewal will have a profound impact on theoretical and practical aspects of bladder cancer. Theoretic signfiicance relates to determiation of pathways involved in initiation while practical significance relates to development of therapeutic strategies of prevention.
期刊论文(37)
专著(0)
科研奖励(0)
会议论文
Cyclic adenosine monophosphate response in primary and subcultured bladder epithelial cells: inhibition by 12-O-tetradecanoylphorbol-13-acetate.
原代和传代培养的膀胱上皮细胞中的环状单磷酸腺苷反应:12-O-十四烷酰佛波醇-13-乙酸酯的抑制。
DOI: 10.1016/0026-0495(93)90077-2
发表时间: 1993
期刊: Metabolism: clinical and experimental
影响因子: --
作者: [Thomas,DJ, Zenser,TV, Davis,BB]
通讯作者: Davis,BB
Mechanism of 12-O-tetradecanoylphorbol-13-acetate enhanced metabolism of arachidonic acid in dog urothelial cells.
12-O-十四烷酰佛波醇-13-乙酸酯增强狗尿路上皮细胞花生四烯酸代谢的机制。
DOI: --
发表时间: 1990
期刊: Cancer research
影响因子: 11.2
作者: [Zenser,TV, Eling,TE, Duniec,ZM, Wong,YH, Davis,BB]
通讯作者: Davis,BB
DOI: 10.1080/00325481.1985.11699066
发表时间: 1985
期刊: Postgraduate medicine
影响因子: 4.2
作者: [Purtilo,DT, Cohen,SM]
通讯作者: Cohen,SM
Peroxidase metabolism of the urinary bladder carcinogen 2-amino-4-(5-nitro-2-furyl)thiazole.
膀胱致癌物2-氨基-4-(5-硝基-2-呋喃基)噻唑的过氧化物酶代谢。
DOI: --
发表时间: 1983
期刊: Cancer research
影响因子: 11.2
作者: [Wise,RW, Zenser,TV, Davis,BB]
通讯作者: Davis,BB
35
    METABOLISM OF N ACETYLBENZIDINE & INITIATION OF BLADDER CANCER
    • 批准号:
      7180145
    • 项目类别:
    • 资助金额:
      $0.65万
    • 财政年份:
      2005
    • 负责人:
      TERRY V ZENSER
    • 依托单位:
    N-ACETYLBENZIDINE DNA ADDUCT FORMATION BY BLADDER CELLS
    • 批准号:
      6173107
    • 项目类别:
    • 资助金额:
      $21.16万
    • 财政年份:
      1998
    • 负责人:
      TERRY V ZENSER
    • 依托单位:
    N-ACETYLBENZIDINE DNA ADDUCT FORMATION BY BLADDER CELLS
    • 批准号:
      2696342
    • 项目类别:
    • 资助金额:
      $21.19万
    • 财政年份:
      1998
    • 负责人:
      TERRY V ZENSER
    • 依托单位:
    N-ACETYLBENZIDINE DNA ADDUCT FORMATION BY BLADDER CELLS
    • 批准号:
      2895754
    • 项目类别:
    • 资助金额:
      $22.54万
    • 财政年份:
      1998
    • 负责人:
      TERRY V ZENSER
    • 依托单位:
    国内基金
    海外基金
    Aspirin调控AKT/Foxo3a/BIM通路延缓吡咯替尼耐药作用机制研究
    Aspirin与自噬通路及核转录因子FoxG1在听觉系统退行性变中的协同调控机制研究
    • 批准号:
      81800915
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      21.0万元
    • 批准年份:
      2018
    • 负责人:
      贺祖宏
    • 依托单位:
    Aspirin联合牙周膜干细胞再生全脱位牙牙周组织机制研究
    • 批准号:
      81760190
    • 项目类别:
      地区科学基金项目
    • 资助金额:
      32.0万元
    • 批准年份:
      2017
    • 负责人:
      王璇
    • 依托单位:
    可注射温敏型水凝胶缓释Aspirin碳点和EPO促牙周组织再生的研究
    • 批准号:
      81600879
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      17.0万元
    • 批准年份:
      2016
    • 负责人:
      徐晓薇
    • 依托单位: